TELETRADER News
6/22, 2:20 AM (Source: TeleTrader)
more TeleTrader news

Cuba claims its three-shot COVID vaccine is 92% effective

Cuban health officials announced that the country's COVID-19 vaccine dubbed Abdala showed 92.28% efficacy in the third phase of the jab's clinical trial.

The latest trial stage of the three-shot vaccine included 48,000 participants, while the rollout of the jab began in May.

Earlier this week, health authorities from Havana unveiled that Soberana II, another Cuban homegrown coronavirus jab, is 62% effective against the virus.

Breaking the News / BU